Boston Scientific Corporation (BSX), Edwards Lifesciences Corp (EW): An Easy Way to Profit From Obamacare-Driven Health-Care Growth

Other companies didn’t do quite as well over the last year, but could see their fortunes change in the coming years. Heart-valve maker Edwards Lifesciences Corp (NYSE:EW) sank by 32%. It had a sharp drop in April, when it posted disappointing earnings results for its first quarter, and lowered its guidance. It has disappointed before, and also has to contend with some cranky workers. Its second quarter was different, though, exceeding expectations on solid sales of its Sapien valve. It gained approval in Japan, as well. Edwards Lifesciences Corp (NYSE:EW) recently won a patent infringement case against Medtronic, a huge medical-device maker. (To be clear, Medtronic is a huge company that makes medical devices, not a company that makes huge medical devices!)

The big picture
Demand for health care isn’t going away anytime soon. A well-chosen ETF can grant you instant diversification across any industry or group of companies — and make investing in and profiting from it that much easier.

The article An Easy Way to Profit From Obamacare-Driven Health-Care Growth originally appeared on Fool.com is written by Selena Maranjian.

Longtime Fool contributor Selena Maranjian, whom you can follow on Twitter, owns shares of MAKO Surgical and Medtronic. The Motley Fool recommends MAKO Surgical. The Motley Fool owns shares of Medtronic. 

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.